Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 146

1.

Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis.

Li YH, Tavallaee G, Tokar T, Nakamura A, Sundararajan K, Weston A, Sharma A, Mahomed NN, Gandhi R, Jurisica I, Kapoor M.

Osteoarthritis Cartilage. 2016 Apr 30. pii: S1063-4584(16)30057-7. doi: 10.1016/j.joca.2016.04.019. [Epub ahead of print]

PMID:
27143365
2.

Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.

Cinegaglia NC, Andrade SC, Tokar T, Pinheiro M, Severino FE, Oliveira RA, Hasimoto EN, Cataneo DC, Cataneo AJ, Defaveri J, Souza CP, Marques MM, Carvalho RF, Coutinho LL, Gross JL, Rogatto SR, Lam WL, Jurisica I, Reis PP.

Oncotarget. 2016 Apr 12. doi: 10.18632/oncotarget.8713. [Epub ahead of print]

3.

Robust quantitative scratch assay.

Vargas A, Angeli M, Pastrello C, McQuaid R, Li H, Jurisicova A, Jurisica I.

Bioinformatics. 2016 May 1;32(9):1439-40. doi: 10.1093/bioinformatics/btv746. Epub 2015 Dec 31.

4.

Fundamentals of protein interaction network mapping.

Snider J, Kotlyar M, Saraon P, Yao Z, Jurisica I, Stagljar I.

Mol Syst Biol. 2015 Dec 17;11(12):848. doi: 10.15252/msb.20156351. Review.

5.

Uninterrupted Sedentary Behavior Downregulates BRCA1 Gene Expression.

Pettapiece-Phillips R, Kotlyar M, Chehade R, Salmena L, Narod SA, Akbari M, Jurisica I, Kotsopoulos J.

Cancer Prev Res (Phila). 2016 Jan;9(1):83-8. doi: 10.1158/1940-6207.CAPR-15-0291. Epub 2015 Nov 2.

PMID:
26526989
6.

Integrated interactions database: tissue-specific view of the human and model organism interactomes.

Kotlyar M, Pastrello C, Sheahan N, Jurisica I.

Nucleic Acids Res. 2016 Jan 4;44(D1):D536-41. doi: 10.1093/nar/gkv1115. Epub 2015 Oct 29.

7.

Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.

Benleulmi-Chaachoua A, Chen L, Sokolina K, Wong V, Jurisica I, Emerit MB, Darmon M, Espin A, Stagljar I, Tafelmeyer P, Zamponi GW, Delagrange P, Maurice P, Jockers R.

J Pineal Res. 2016 Jan;60(1):95-108. doi: 10.1111/jpi.12294. Epub 2015 Nov 30.

PMID:
26514267
8.

An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer.

Agostini M, Janssen KP, Kim IJ, D'Angelo E, Pizzini S, Zangrando A, Zanon C, Pastrello C, Maretto I, Digito M, Bedin C, Jurisica I, Rizzolio F, Giordano A, Bortoluzzi S, Nitti D, Pucciarelli S.

Oncotarget. 2015 Oct 20;6(32):32561-74. doi: 10.18632/oncotarget.4935.

9.

STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation.

Singh M, Garg N, Venugopal C, Hallett R, Tokar T, McFarlane N, Mahendram S, Bakhshinyan D, Manoranjan B, Vora P, Qazi M, Arpin CC, Page B, Haftchenary S, Rosa DA, Lai PS, Gómez-Biagi RF, Ali AM, Lewis A, Geletu M, Murty NK, Hassell JA, Jurisica I, Gunning PT, Singh SK.

Oncotarget. 2015 Sep 29;6(29):27461-77. doi: 10.18632/oncotarget.4742.

10.

Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.

Navab R, Strumpf D, To C, Pasko E, Kim KS, Park CJ, Hai J, Liu J, Jonkman J, Barczyk M, Bandarchi B, Wang YH, Venkat K, Ibrahimov E, Pham NA, Ng C, Radulovich N, Zhu CQ, Pintilie M, Wang D, Lu A, Jurisica I, Walker GC, Gullberg D, Tsao MS.

Oncogene. 2016 Apr 14;35(15):1899-908. doi: 10.1038/onc.2015.254. Epub 2015 Jul 6.

11.

Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.

Stewart EL, Mascaux C, Pham NA, Sakashita S, Sykes J, Kim L, Yanagawa N, Allo G, Ishizawa K, Wang D, Zhu CQ, Li M, Ng C, Liu N, Pintilie M, Martin P, John T, Jurisica I, Leighl NB, Neel BG, Waddell TK, Shepherd FA, Liu G, Tsao MS.

J Clin Oncol. 2015 Aug 1;33(22):2472-80. doi: 10.1200/JCO.2014.60.1492. Epub 2015 Jun 29.

PMID:
26124487
12.

A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.

Agostini M, Zangrando A, Pastrello C, D'Angelo E, Romano G, Giovannoni R, Giordan M, Maretto I, Bedin C, Zanon C, Digito M, Esposito G, Mescoli C, Lavitrano M, Rizzolio F, Jurisica I, Giordano A, Pucciarelli S, Nitti D.

Cancer Biol Ther. 2015;16(8):1160-71. doi: 10.1080/15384047.2015.1046652. Epub 2015 May 29.

PMID:
26023803
13.

Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data.

Fortney K, Griesman J, Kotlyar M, Pastrello C, Angeli M, Sound-Tsao M, Jurisica I.

PLoS Comput Biol. 2015 Mar 18;11(3):e1004068. doi: 10.1371/journal.pcbi.1004068. eCollection 2015 Mar.

14.

Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplant.

Camargo JF, Resende MR, Zamel R, Klement W, Bhimji A, Huibner S, Kumar D, Humar A, Jurisica I, Keshavjee S, Kaul R, Husain S.

Clin Transplant. 2015 Jun;29(6):492-8. doi: 10.1111/ctr.12531. Epub 2015 Apr 22.

PMID:
25690781
15.

Where are we at regarding species translation? A review of the sbv IMPROVER challenge.

Hoeng J, Peitsch MC, Meyer P, Jurisica I.

Bioinformatics. 2015 Feb 15;31(4):451-2. doi: 10.1093/bioinformatics/btv065. Epub 2015 Jan 31. No abstract available.

16.

Integrating RAS status into prognostic signatures for adenocarcinomas of the lung.

Starmans MH, Pintilie M, Chan-Seng-Yue M, Moon NC, Haider S, Nguyen F, Lau SK, Liu N, Kasprzyk A, Wouters BG, Der SD, Shepherd FA, Jurisica I, Penn LZ, Tsao MS, Lambin P, Boutros PC.

Clin Cancer Res. 2015 Mar 15;21(6):1477-86. doi: 10.1158/1078-0432.CCR-14-1749. Epub 2015 Jan 21.

17.

Kinome-wide screening of HER2+ breast cancer cells for molecules that mediate cell proliferation or sensitize cells to trastuzumab therapy.

Lapin V, Shirdel EA, Wei X, Mason JM, Jurisica I, Mak TW.

Oncogenesis. 2014 Dec 15;3:e133. doi: 10.1038/oncsis.2014.45.

18.

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.

Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, Dunning MJ, Halim S, Lamb AD, Moon NC, Zafarana G, Warren AY, Meng X, Thoms J, Grzadkowski MR, Berlin A, Have CL, Ramnarine VR, Yao CQ, Malloff CA, Lam LL, Xie H, Harding NJ, Mak DY, Chu KC, Chong LC, Sendorek DH, P'ng C, Collins CC, Squire JA, Jurisica I, Cooper C, Eeles R, Pintilie M, Dal Pra A, Davicioni E, Lam WL, Milosevic M, Neal DE, van der Kwast T, Boutros PC, Bristow RG.

Lancet Oncol. 2014 Dec;15(13):1521-32. doi: 10.1016/S1470-2045(14)71021-6. Epub 2014 Nov 13.

19.

BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.

Dingar D, Kalkat M, Chan PK, Srikumar T, Bailey SD, Tu WB, Coyaud E, Ponzielli R, Kolyar M, Jurisica I, Huang A, Lupien M, Penn LZ, Raught B.

J Proteomics. 2015 Apr 6;118:95-111. doi: 10.1016/j.jprot.2014.09.029. Epub 2014 Oct 18.

PMID:
25452129
20.

NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.

Berlin A, Lalonde E, Sykes J, Zafarana G, Chu KC, Ramnarine VR, Ishkanian A, Sendorek DH, Pasic I, Lam WL, Jurisica I, van der Kwast T, Milosevic M, Boutros PC, Bristow RG.

Oncotarget. 2014 Nov 30;5(22):11081-90.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk